Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

Table 1

Cancer-associated glycan alterations observed in the referred studies.

Structure	Findings	References
T antigen	Overexpression	[14–16]
Sialyl-T antigen	Overexpression	[12, 14]
Tn antigen	Overexpression	[17–20]
Sialyl-Tn antigen	Overexpression	[17, 18, 20–22]
Sialyl-Lewis^a	Overexpression	[23–27]
Sialyl-Lewis^x	Overexpression	[28–30]
Core-2	Overexpression/underexpression	[12, 31]
Core-3	Underexpression	[12, 31]
Core-4	Underexpression	[12, 31]
β1-6 branching of N-glycans	Overexpression	[32, 33]
Fucosylation	Overexpression	[34–37]
Sialylation	Overexpression	[38, 39]